Showing results (161-170 of 1,561) with videos related to
Sort By:
Pageof 157
Child Psychiatry and Human Development|January 1, 1975
A guide to differentiated developmental diagnosis with a case demonstrating its useB Klein, J MordockDermatologica|January 1, 1989
Normalization of skin appearance in a patient with scleromyxoedema after intensive chemotherapy for Hodgkin's diseaseA S Alberts, E J Schulz, G Falkson, et al.Cancer Treatment Reports|January 1, 1981
Trials of single-agent and combination chemotherapy for advanced cancer of the pancreasJ Horton, R D Gelber, P Engstrom, et al.Cancer|September 1, 1978
Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapyH C Falkson, J J Van Der Watt, M A Portugal, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Ten-year follow-up study of premenopausal women with metastatic breast cancer: an Eastern Cooperative Oncology Group studyG Falkson, C Holcroft, R S Gelman, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1991
Cisplatin, carboplatin, and cyclophosphamide combination chemotherapy in advanced-stage ovarian carcinoma: an Eastern Cooperative Oncology Group pilot studyJ Grem, P O'Dwyer, P Elson, et al.Cancer|May 1, 1982
Carcinoembryonic antigen as a marker in patients with breast cancer receiving postsurgical adjuvant chemotherapyH C Falkson, G Falkson, M A Portugal, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|December 20, 1986
Prognostic factors in patients with small-cell carcinoma of the lungM R Chasen, G Falkson, C A van der Merwe, et al.Cancer Treatment Reports|August 1, 1979
Role of plasma carcinoembryonic antigen in evaluating patients with breast cancer treated with adjuvant chemotherapyH C Falkson, J J van der Watt, M A Portugal, et al.Investigational New Drugs|November 1, 1992
An extended phase II trial of ifosfamide plus mesna in malignant mesotheliomaG Falkson, M Hunt, E C Borden, et al.Pageof 157